Flutter and Cure Leukaemia Partnership

Organised by Cure Leukaemia

Cure Leukaemia are thrilled to announce that global sports gaming provider, Flutter are the new headline partner of Cure Leukaemia’s flagship event, “The Tour 21” for the 2023, 2024 and 2025 editions of the £1million fundraising event.

Be a fundraiser

Create your own fundraising page and help support this cause.

Start fundraising
With a new blood cancer diagnosis every 27 seconds worldwide, Cure Leukaemia funds research nurses at UK blood cancer centres, giving patients access to treatments through clinical trials. This support drives global significant advancements in blood cancer, impacting those affected by the disease.

Story

Cure Leukaemia are thrilled to announce that global sports gaming provider, Flutter are the new headline partner of Cure Leukaemia’s flagship event, “The Tour 21” for the 2023, 2024 and 2025 editions of the £1million fundraising event.

The Tour 21 in partnership with Flutter, takes place one week ahead of the professional race and sees a team of 19 amateur cyclists aiming to complete all 21 stages, over 3,000km, of the iconic Tour de France raising in excess of £1,000,000 for the charity and funding globally significant advances in blood cancer treatment. The 2023 event takes place from Friday 23rd June, starting in Bilbao, before finishing in central Paris on Sunday 16th July.

Flutter is the world’s leading online sports betting and gaming company, operating some of the most innovative, diverse and distinctive brands in the sector. For Flutter, it’s all about bringing entertainment to life for millions of customers in a safe, responsible and sustainable way.

The Tour 21 and Cure Leukaemia’s work to improve treatment and find a cure for blood cancer aligns with Flutter’s community based goal to “improve the lives of 10 million people using the power of sport, the skills of colleagues and the reach of the brand by 31 December 2030.”

Funds raised from The Tour 21 in partnership with Flutter is invested directly into the Trials Acceleration Programme (TAP) network which Cure Leukaemia began funding in January 2020.

A team of specialist research nurses and other clinical roles require funding of over £1million each year and facilitate pioneering treatments for blood cancer, a disease that over 250,000 in the UK currently live with and someone is diagnosed with every 14 minutes.

The TAP network consists of 15 centres across the UK’s biggest cities and covers a catchment area of over 20million people, providing access to potentially life-saving treatments not available through standard care.

Help Cure Leukaemia

Sharing this cause with your network could help raise up to 5x more in donations. Select a platform to make it happen:

You can also help by sharing this link on:

Donation summary

Total
£4,715.99
+ £726.25 Gift Aid
Online
£4,715.99
Offline
£0.00
Direct
£46.49
Fundraisers
£4,669.50

Charities pay a small fee for our service. Learn more about fees